Professor David Price
Chair of Primary Care Respiratory Med
- ºÚÁÏÍø
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 25 of 98 Results 241 to 250 of 976
Persistent reductions in OCS use in patients with severe, OCS dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
World Allergy Congress 2022, pp. 383Contributions to Journals: Abstracts- [ONLINE]
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
European Respiratory Society (ERS) International Congress., 3305Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Risk factors for corticosteroid- and antibiotic only-treated asthma attacks in the NOVELTY cohort
European Respiratory Society (ERS) International Congress., 2125Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
What have we learnt from real-life research in asthma and COPD?: Standards and novel designs for the future
Respirology, vol. 27, no. 12, pp. 1018-1021Contributions to Journals: Comments and Debates- [ONLINE] DOI:
Effectiveness of initiating biologics in severe asthma patients with high steroid exposure
European Respiratory Society (ERS) International Congress., 3405Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Proactive Risk Management: A Novel Approach to Embedding Oral Corticosteroid Stewardship into Asthma Care
European Medical Journal - Respiratory, vol. 10, no. Supplement 2Contributions to Journals: Articles- [ONLINE]
- [OPEN ACCESS]
Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
British Thoracic Society Winter Meeting 2022, pp. A54Contributions to Conferences: Abstracts- [ONLINE]
- [ONLINE]
S88 Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
Thorax, vol. 77, no. Suppl. 1, pp. A54Contributions to Journals: Abstracts- [ONLINE] DOI:
- [ONLINE]
P186 Facilitators to recruiting COPD patients to an adherence intervention trial
Thorax, vol. 77, no. Suppl. 1, A182Contributions to Journals: Abstracts- [ONLINE] DOI:
Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial
British Thoracic Society Winter Meeting 2022, pp. A72-A73Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [ONLINE]